Richard Ivell

University Park
Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Childhood Vitamin D Status and Circulating Insulin-like Peptide 3 as a Marker of Leydig Cell Functional Capacity in Young Adulthood: Findings from the Avon Longitudinal Study of Parents and Children.

Childhood Vitamin D Status and Circulating Insulin-like Peptide 3 as a Marker of Leydig Cell Functional Capacity in Young Adulthood: Findings from the Avon Longitudinal Study of Parents and Children.

Journal: Nutrients

Published: July 01, 2026

Association between COVID-19 status and Leydig cell functional capacity among men in hospitalized cohorts.

Association between COVID-19 status and Leydig cell functional capacity among men in hospitalized cohorts.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: March 28, 2026

Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma.

Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma.

Journal: Frontiers in endocrinology

Published: May 09, 2025

Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index.

Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index.

Journal: Andrology

Published: April 19, 2025

Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index.

Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index.

Journal: Andrology

Published: April 19, 2025

Defining the end of puberty in boys: INSL3 and the acute determinants of adult Leydig-cell functional capacity.

Defining the end of puberty in boys: INSL3 and the acute determinants of adult Leydig-cell functional capacity.

Journal: Frontiers in endocrinology

Published: February 11, 2025

Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold.

Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: April 27, 2024

The proliferation of derivative and redundant studies in endocrinology due to the application of Mendelian Randomisation and other methods to open databases.

The proliferation of derivative and redundant studies in endocrinology due to the application of Mendelian Randomisation and other methods to open databases.

Journal: Frontiers in endocrinology

Published: March 13, 2024

INSL3 Variation in Dogs Following Suppression and Recovery of the HPG Axis.

INSL3 Variation in Dogs Following Suppression and Recovery of the HPG Axis.

Journal: Animals : an open access journal from MDPI

Published: January 23, 2024

Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men.

Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men.

Journal: Frontiers in endocrinology

Published: October 22, 2022

The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.

The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.

Journal: Frontiers in endocrinology

Published: August 10, 2022

Influence on the adult male Leydig cell biomarker insulin-like peptide 3 of maternal exposure to estrogenic and anti-androgenic endocrine disrupting compound mixtures: A retrospective study.

Influence on the adult male Leydig cell biomarker insulin-like peptide 3 of maternal exposure to estrogenic and anti-androgenic endocrine disrupting compound mixtures: A retrospective study.

Journal: Andrologia

Published: June 21, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026